Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Oncogene inactivation in a mouse model

Tissue invasion by leukaemic cells is stalled by loading them with a designer ribozyme.

Abstract

Chronic myelogenous leukaemia (CML) is a haematopoietic malignant disease associated with the expression of a chimaeric BCR–ABL gene1,2. We have designed an allosterically controllable ribozyme that specifically cleaves BCR–ABL messenger RNA and induces apoptosis in cultured CML cells3, and here we test it as a possible treatment of CML in a mouse model. We find that this ribozyme completely inhibits tumour-cell infiltration in these mice. To our knowledge, this is the first application of an artificial, allosterically controllable enzyme in animals, opening up the possibility of using ribozyme technology in the treatment of CML.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The antitumour effects of the maxizyme in a murine model of chronic myelogenous leukaemia (CML).

Similar content being viewed by others

References

  1. Bartram, C. R. et al. Nature 306, 277–280 (1983).

    Article  ADS  CAS  Google Scholar 

  2. Konopka, J. B., Watanabe, S. M. & Witte, O. N. Cell 37, 1035– 1042 (1984).

    Article  CAS  Google Scholar 

  3. Kuwabara, T. et al. Mol. Cell 2, 617–627 (1998).

    Article  CAS  Google Scholar 

  4. Daley, G. Q., Van Etten, R. A. & Baltimore, D. Science 247, 824– 830 (1990).

    Article  ADS  CAS  Google Scholar 

  5. Gishizky, M. L. & Witte, O. N. Science 256, 836–839 (1992).

    Article  ADS  CAS  Google Scholar 

  6. Amontov, S. & Taira, K. J. Am. Chem. Soc. 118, 1624–1628 (1996).

    Article  CAS  Google Scholar 

  7. Kuwabara, T. et al. Nature Biotechnol. 16, 961– 965 (1998).

    Article  CAS  Google Scholar 

  8. Kuwabara, T., Warashina, M., Nakayama, A., Ohkawa, J. & Taira, K. Proc. Natl Acad. Sci. USA 96, 1886–1891 (1999).

    Article  ADS  CAS  Google Scholar 

  9. Onishi, M. Exp. Hematol. 24, 324–329 (1996).

    CAS  PubMed  Google Scholar 

  10. Snyder, D. S. & McGlave, P. B. Hematol. Oncol. Clin. North Am. 4, 535–557 ( 1990).

    Article  CAS  Google Scholar 

  11. McGlave, P. B. et al. Blood 81, 543–550 (1993).

    Article  CAS  Google Scholar 

  12. Deisseroth, A. B. et al. Blood 83, 3068 ( 1994).

    Article  CAS  Google Scholar 

  13. Tanabe, T. et al. Biomacromolecules 1, 108– 117 (2000).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kazunari Taira.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tanabe, T., Kuwabara, T., Warashina, M. et al. Oncogene inactivation in a mouse model. Nature 406, 473–474 (2000). https://doi.org/10.1038/35020190

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/35020190

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing